Stocks · Health care · Biological Products, (No Diagnostic Substances)

Replimune Group, Inc.

REPL Clue Score21

United States Fiscal year ends March CIK 0001737953 Results filed 28 Oct 2026

Add to watchlist

What the insiders did Scheduled selling only

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$408.50K

$0.00 on a plan · $408.50K straight out of an exercise

Sold at will

$0.00

0 of 1 sales

Net

−$408.50K

$0.00 against sales at will